Moody Aldrich Partners’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-37,570
Closed -$1.39M 170
2022
Q3
$1.39M Buy
+37,570
New +$1.39M 0.29% 103